Rapport Therapeutics, Inc. (RAPP) Reports Q1 Loss of $0.42

Rapport Therapeutics, Inc. (NASDAQ: RAPP) reported Q1 EPS of ($0.42). Revenue for the quarter came in at $20 million.

For earnings history and earnings-related data on Rapport Therapeutics, Inc. (RAPP) click here.

You May Also Be Interested In

• Hawaiian Electric trades at 8.8x P/E, but wildfire risk clouds value case
• C3 AI (AI) call put ratio 1.6 calls to 1 put into quarter results
• Vishay launches two common mode chokes for automotive and industrial use